High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: A Prespecified Secondary Analysis of the DANFLU-2 Randomized Clinical Trial

Cardiovascular Risk and DiseasesFurther Publications
Do you want to read an article? Please log in or register.